See All Slides - tctmd.com

Slides

Presentation TCT 2013

Understanding the FDA Panel Decision to Approve MitraClip

Presenter: Mitchell Krucoff

October 30, 2013

Presentation TCT 2013

Case Presentation: Severe AS and Coronary Artery Disease

Presenter: Sachin Goel

October 30, 2013

Presentation TCT 2013

How Would I Treat This Patient?(4)

Presenter: Adel Etriby

October 30, 2013

Presentation TCT 2013

JCAHO in the Cath Lab

Presenter: Bernadette Speiser

October 30, 2013

Presentation TCT 2013

Regulatory Approval Models for New TAVR "In Class" Devices: Are We Back to the Days of Device vs. Device RCTs?

Presenter: E. Murat Tuzcu

October 30, 2013

Presentation TCT 2013

ICE Guidance of TAVR (and Other Structural Heart Intervention)

Presenter: Brij Maini

October 30, 2013

Presentation TCT 2013

Expansion of Primary PCI Hospitals to Broaden the STEMI Net: Right Idea, Misguided Implementation?

Presenter: Gregory Dehmer

October 30, 2013

Presentation TCT 2013

TCT-122. Electrode irrigation alters RF ablation treatment zone geometry and preserves medial and adventitial tissue while maintaining injury to renal nerves

Presenter: Elazer Edelman

October 30, 2013

Presentation TCT 2013

Current Review of AAA Endografts and Newly Approved Devices: Matching the Device to the Patient

Presenter: David Deaton

October 30, 2013

Presentation TCT 2013

When Is Fibrinolysis Appropriate in STEMI? US and European Guideline Perspectives

Presenter: Eric Bates

October 30, 2013

Advertisement

Slides

Understanding the FDA Panel Decision to Approve MitraClip

Case Presentation: Severe AS and Coronary Artery Disease

How Would I Treat This Patient?(4)

JCAHO in the Cath Lab

Regulatory Approval Models for New TAVR "In Class" Devices: Are We Back to the Days of Device vs. Device RCTs?

ICE Guidance of TAVR (and Other Structural Heart Intervention)

Expansion of Primary PCI Hospitals to Broaden the STEMI Net: Right Idea, Misguided Implementation?

TCT-122. Electrode irrigation alters RF ablation treatment zone geometry and preserves medial and adventitial tissue while maintaining injury to renal nerves

Current Review of AAA Endografts and Newly Approved Devices: Matching the Device to the Patient

When Is Fibrinolysis Appropriate in STEMI? US and European Guideline Perspectives

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content